Legend Biotech Corporation (LEGN)

NASDAQ: LEGN · Real-Time Price · USD

29.30

-0.04 (-0.14%)

At close: Jun 23, 2026, 4:00 PM EDT

29.24

-0.06 (-0.19%)

After-hours: Jun 23, 2026, 7:47 PM EDT

Legend Biotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,139	1,029	627.3	285.1	117.01	68.83
Revenue Growth (YoY)	56.38%	64.02%	120.03%	143.66%	70.00%	-8.23%
Cost of Revenue	512.7	408.1	234.6	144.2	65.36	-
Gross Profit	626.09	620.8	392.7	140.9	51.64	68.83
Selling, General & Admin	359.27	341.6	284.3	201	174.05	149.5
Research & Development	398.45	414.7	413.5	382.2	335.65	313.35
Other Operating Expenses	-	1	4.4	85.8	-23.13	12.27
Total Operating Expenses	757.72	757.3	702.2	669	486.57	475.12
Operating Income	-131.63	-136.5	-309.5	-528.1	-434.93	-406.3
Interest Income	35.29	40.1	61.2	54.5	-	-
Interest Expense	-21.86	-21.4	-21.6	-21.8	-10.8	-0.9
Other Non-Operating Income (Expense)	-115.27	-164.8	111.8	-24.8	-	-
Total Non-Operating Income (Expense)	-101.84	-146.1	151.4	7.9	-10.8	-0.9
Pretax Income	-236.67	-282.6	-158.1	-520.2	-445.72	-407.2
Provision for Income Taxes	2.4	14.2	18.9	-1.9	0.63	-3.61
Net Income	-239.07	-296.8	-177	-518.3	-446.35	-403.58
Net Income to Common	-250.27	-296.8	-177	-518.3	-446.35	-403.58
Shares Outstanding (Basic)	185	184	183	176	159	141
Shares Outstanding (Diluted)	185	184	183	176	159	141
Shares Change (YoY)	-1.65%	0.80%	3.84%	10.71%	12.91%	19.21%
EPS (Basic)	-1.36	-1.62	-0.96	-2.94	-2.80	-2.86
EPS (Diluted)	-1.36	-1.62	-0.96	-2.94	-2.80	-2.86
Free Cash Flow	-115.8	-128.8	-158.1	-413.4	-222.21	-240.66
Free Cash Flow Per Share	-0.63	-0.70	-0.86	-2.35	-1.40	-1.71
Gross Margin	54.98%	60.34%	62.60%	49.42%	44.14%	100.00%
Operating Margin	-11.56%	-13.27%	-49.34%	-185.23%	-371.72%	-590.32%
Profit Margin	-20.99%	-28.85%	-28.22%	-181.80%	-381.48%	-586.38%
FCF Margin	-10.17%	-12.52%	-25.20%	-145.00%	-189.91%	-349.67%
EBITDA	-92.12	-107.6	-288.1	-509.6	-416.54	-392.38
EBITDA Margin	-8.09%	-10.46%	-45.93%	-178.74%	-356.00%	-570.10%
EBIT	-131.63	-136.5	-309.5	-528.1	-434.93	-406.3
EBIT Margin	-11.56%	-13.27%	-49.34%	-185.23%	-371.72%	-590.32%
Effective Tax Rate	-1.01%	-5.02%	-11.95%	0.37%	-0.14%	0.89%

SEC Filings: 10-K · 10-Q